Pharmaceutical care for patients with diabetes: storage of insulin
Abstract
According to statistics, 1.2 million Ukrainians suffer from diabetes, and 201626 people being registered and requiring insulin (PI). In Ukraine, a system of reimbursement is introduced, which provides for the dispatch of PI from pharmacies. Thus, in the process of providing patients with diabetes with insulin, pharmacies play a significant role and, accordingly, provide them with pharmaceutical assistance. Insulin is used to treat both type 1 and type 2 diabetes mellitus. Successful treatment requires confidence that the insulin will work properly. Improper storage can lead to a decrease in insulin activity, which will affect its ability to effectively and predictably control the patient's blood sugar. It is important to provide the patient with correct recommendations for storing insulin when dispensed from the pharmacy.
The purpose of the work was to develop practical recommendations for pharmacy workers and patients with diabetes mellitus regarding the storage of PI.
The objects of study were electronic and paper sources of information, Instructions for the use of PI. Content analysis and methods of bibliosemantic, marketing, generalization analyzes were applied.
Marketing research of PIs whose names are subject to reimbursement on dispensing from pharmacies showed that the number of trade names is 33 names, and taking into account the dosage form – 71. In the bottles are represented 39.4% of drugs, in cartridges – 33.8% and in pre-filled syringes pens – 26.8%. PIs are supplied to the Ukrainian pharmaceutical market by domestic manufacturers, foreign companies and joint ventures. In this case, PIs in bottles are manufactured mainly by domestic manufacturers (16 preparations), cartridge forms – mainly by foreign companies (14 preparations), and pre-filled syringe pens – only by foreign companies (19 preparations). The joint ventures produce only 7 items in vials and cartridges.
On the basis of the analysis of documents from different countries, the latest scientific researches and instructions for the use of PI, detailed recommendations have been developed, both for pharmacy workers and for patients with diabetes mellitus, for insulin storage. Attention is drawn to the high risk of exposure to temperature during storage and to the prevention of these risks. The recommendations are developed from the point of view of practical application. Separately formulated tips for storing insulin while traveling. The guidelines are designed to provide pharmaceutical assistance to patients with diabetes at an appropriate level with the release of PI. The issue of proper storage of PIs should be included in the undergraduate and postgraduate training of physicians, nurses, pharmacists and pharmacists. Government agencies should promote a coherent approach to the delivery of medical and pharmaceutical care through the development of national recommendations.
References
2. Informatsiini materialy do zasidannia Komitetu Verkhovnoi Rady Ukrainy z pytan okhorony zdorovia vid 7 lystopada 2018 «Pro stan finansuvannia zabezpechennia potreb khvorykh na tsukrovyi diabet u preparatakh insulinu u 2018 rotsi». – 2018. – 15 s.
3. Nakaz MOZ vid 21. 01. 2019 r. № 148 «Pro zatverdzhennia Reiestru likarskykh zasobiv, vartist yakykh pidliahaie vidshkoduvanniu stanom na 21 sichnia 2019 r.». – URL: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-21012019--148-pro-zatverdzhennja-reestru-likarskih-zasobiv-vartist-jakih-pidljagae-vidshkoduvannju-stanom-na-21-sichnja-2019-roku
4. Postanova Kabinetu Ministriv Ukrainy vid 17 bereznia 2017 roku № 152 «Pro zabezpechennia dostupnosti likarskykh zasobiv». – URL: https://www.apteka.ua/article/404701
5. Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services from the WHO technical report series, N 961// World Health Organization, 2011. – URL: http://apps.who.int/medicinedocs/documents/s18676en/s18676en.pdf
6. WHO Expert Committee on Specifications for Pharmaceutical Preparations 46 report. WHO Technical Report Series, No. 970, 2012, 235 p. – URL: http://apps.who.int/medicinedocs/documents/s20174en/s20174en.pdf
7. WHO Model List of Essential Medicines. – URL: https://www.who.int/selection_medicines/list/en/]
8. Storing Insulin. – URL: https://www.iddt.org/about/living-with-diabetes/storing-insulin
9. Arpit B., Varun G., Prashant T. et al. Last mile delivery of cold chain medicines — challenges and recommendations // Indian J. Pharm. Biol. Res. – 2018. – N 6 (1). – P. 34–41. – URL: http://ijpbr.in/pdf/6-Last-Mile-Delivery-of-Cold-Chain-Medicines-Challenges-and-Recommendations.pdf
10. Chandler C., Gryniewicz C. M., Pringle T., Cunningham F. Insulin temperature and stability under simulated transit conditions // Amer. J. Health-System Pharmacy. – 2008. – N 65 (10). – P. 953–963. https://doi.org/10.2146/ajhp070347
11. Derzhavnyi reiestr likarskykh zasobiv. – URL: http://www.drlz.com.ua
12. European Medicines Agency (EMA). – URL: https://www.ema.europa.eu
13. European Commission. Guidelines of 5 November 2013 on Good Distribution Practice of Medicinal Products for Human Use. Official Journal of the European Union. Commission guideline 2013. C. 343/01–343/14. – URL: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2013:343:0001:0014:EN:PDF
14. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products. WHO Technical Report Series, No. 961, Annex 9; 2011. – URL: http://apps.who.int/medicinedocs/documents/s18683en/s18683en.pdf
15. Food and Drug Administrations. – URL: https://www.fda.gov/consumers/free-publications-women/insulin
16. Nakaz MOZ Ukrainy vid 16. 03. 1993 r. № 44 «Instruktsiia po orhanizatsii zberihannia v aptechnykh zakladakh riznykh hrup likarskykh zasobiv i predmetiv medychnoho pryznachennia». – URL: http://mozdocs.kiev.ua/view.php?id=2028
17. Nakaz Ukrainy vid 03. 02. 2006 r. № 48 «Pro zatverdzhennia Poriadku zabezpechennia nalezhnykh umov zberihannia, transportuvannia, pryimannia ta obliku medychnykh imunobiolohichnykh preparativ v Ukraini». – URL: http://zakon4.rada.gov.ua/laws/show/z0670-06
18. Posylkina O. V., Sahaidak-Nikitiuk R. V., Khromykh A. H., Novytska Yu. Ye. Kerivnytstvo protsesu stvorennia intehrovanoho kholodovoho lantsiuha postachannia biotekhnolohichnykh likarskykh zasobiv. – Kharkiv: NFaU, 2014. – 24 s.
19. Nakaz MOZ Ukrainy 25. 03. 2019 № 666 «REIeSTR referentnykh tsin (tsin vidshkoduvannia) na preparaty insulinu stanom na 01 liutoho 2019 r., shcho pidliahaiut vidshkoduvanniu (abo chastkovomu vidshkoduvanniu). – URL: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-25032019--666-pro-zatverdzhennja-reestru-referentnih-cin-cin-vidshkoduvannja-na-preparati-insulinu-stanom-na-01-ljutogo-2019-roku
20. Insulin Pens welcome back to the Fridge! – URL: https://medangel.co/blog/insulin-pens-are-welcome-back-to-the-fridge-49d37511c88c/
21. Williams A. S. Insulin basics: The reasons behind the recommendations // Voice of the Diabetic. – URL: https://nfb.org/images/nfb/publications/vod/vodsum0401.htm
22. Summary of product characteristics Tresiba, INN-insulin degludec. – URL: https://www.ema.europa.eu/en/documents/product-information/tresiba-epar-product-information_en.pdf
23. Ostman J., Andersson D. Diabetes mellitus in the book: Drugs Swedish pharmaceutical company, 1993. – 474 p.
24. Gregory R., Edwards S., Yateman N. A. Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography // Diabetes Care. – 1991. – N 14 (1). – P. 42–48. – URL: https://www.ncbi.nlm.nih.gov/pubmed/1991434. https://doi.org/10.2337/diacare.14.1.42
25. Vimalavathini R., Gitanjali B. Effect of temperature on the potency & pharmacological action of insulin // Indian J. Med. Res. – 2009. – N 130 (2). – P. 166–169.
26. Grajower M. M., Fraser C. G., Holcombe J. H. et al. How long should insulin be used once a vial is started? // Diabetes Care. – 2003. – N 26 (9). – P. 2665–2666. https://doi.org/10.2337/diacare.26.9.2665
27. Rathod M., Saravolatz L., Pohlod D. et al. Evaluation of the sterility and stability of insulin from multidose vials used for prolonged periods // Infect Control. – 1985. – N 6. – P. 491–494. https://doi.org/10.1017/S019594170006361X
28. Rachel Besser. Type 1 Diabetes in Children, Adolescents and Young Adults : How to Become an Expert on Your Own Diabetes. – CLASS PUBLISHING. Bridgwater, United Kingdom, 2009. – 400 p.
29. Arya S. C. Insulin storage in clay pot. Annals of Saudi Medicine. – 2000. – N 20. – P. 491–492. https://doi.org/10.5144/0256-4947.2000.491a
30. Mahony P. What happens to insulin after it is dispensed? // Material of 15 National Rural Health Conference 24–27 march, 2019 Tasmania. – URL: http://www.ruralhealth.org.au/15nrhc/sites/default/files/PosterPaper_Mahony.pdf
31. Maiorov A. Yu. Melnykova O. H. Natsyonalnіe rekomendayy dlia medytsynskykh rabotnykov po tekhnyke ynъektsyi pry lechenyy sakharnoho dyabeta. – Moskva, 2012. – 43 s.
32. Braune K., Kraemer L. A., Weinstein J. et al. Storage Conditions of Insulin in Domestic Refrigerators and When Carried by Patients: Often Outside Recommended Temperature Range // Diabetes Technology & Therapeutics. – 2019. – N 21(5). – P. 238–244. https://doi.org/10.1089/dia.2019.0046
33. Minuto N., Tambroni B., Vannati M. et al. Diabetic ketoacidosis caused by exposure of insulin to low temperature // Diabetes Technology and Therapeutics. – 2010. – N 12 (9). – P. 745–746. https://doi.org/10.1089/dia.2010.0055
34. Vlieland N. D., Gardarsdottir H., Bouvy M. L. et al. The majority of patients do not store their biologic diseasemodifying antirheumatic drugs within the recommended temperature range // Rheumatology. – 2016. – N 55. – P. 704–709. https://doi.org/10.1093/rheumatology/kev394
35. de Jong M., Pierik M., Peters A. et al. Exploring conditions for redistribution of anti-tumor necrosis factors to reduce spillage: A study on the quality of anti-tumor necrosis factor home storage // J. Gastroenterol. Hepatol. – 2018. – N 33. – P. 426–430. https://doi.org/10.1001/jamaneurol.2018.0605
36. Guidelines for insulin storage and handling. – URL: http://patientinfo.org.au/Resources/Guidelines%20for%20insulin%20storage%20and%20handling.pdf
37. Insulin storage and syringe safety. American Diabetes Association. – URL: http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/insulin/insulin-storage-and-syringe-safety.html
38. Bahendeka S., Kaushik R., Babu Swai A. et al. EADSG Guidelines: Insulin Storage and Optimisation of Injection Technique in Diabetes Management // Diabetes Therapy. – 2019. – N 10 (2). – P. 341–366. https://doi.org/10.1007/s13300-019-0574-x
39. Insulin Recommended Safe Practice Guidelines California Hospital Association Medication Safety Committee. – URL: https://www.calhospital.org/sites/main/files/file-attachments/tk_insulin_guidelines_rev_9-21-17_final.pdf ]
40. Kalra S., Kalra B. Storage of insulin in rural areas // J. Academy of Med. Science. – 2012. – N 2 (2). – P. 86–89. – URL: http://www.e-jams.org/article.asp?issn=2249. https://doi.org/10.4103/2249-4855.118669
41. Practice Guidance on the Care of People with Diabetes. Royal Pharmaceutical Society of Great Britain Diabetes. Task Force, 2004. – 74 p. URL: http://studyres.com/doc/8005614/practice-guidance-on-the-care-of-people-with-diabetes
42. Vlasenko I. O., Davtian L. L., Zhohov I. V. Cuchasni prylady dlia samokontroliu tsukrovoho diabetu // Dyabet. Ozhyrenye. Metabolycheskyi syndrom. – 2013. – № 4.– S. 7–15.
43. Traveling with insulin: How to keep it cool. – URL: https://www.sweettrip.org/traveling-with-insulin/#INSULIN-STORAGE-RULES
44. How to keep insulin cold while traveling: all you need to know! – URL: https://www.dreambigtravelfarblog.com/blog/how-to-keep-insulin-cold-while-traveling
This work is licensed under a Creative Commons Attribution 4.0 International License.
